Invasive multisystemic aspergillosis in an immunocompetent child. Case report;Aspergilosis invasora multisistémica en un niño inmunocompetente. Comunicación de un caso

Revista Chilena de Infectologia

Volumn 23, Issue 1, 2006, Pages 69-72

  Donoso F , Alejandro ^a   Camacho A , Jorge ^a   Alarcón L , Pedro ^a   Cruces R , Pablo ^b  

^a HOSPITAL PADRE HURTADO   (Chile)

^b UNIVERSIDAD DEL DESARROLLO   (Chile)

Author keywords

Aspergillus fumigatus; Immunocompetent; Invasive aspergillosis; Pediatrics

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B, DEOXYCHOLATE DRUG COMBINATION; AMPHOTERICIN B-DEOXYCHOLATE; ANTIFUNGAL AGENT; DEOXYCHOLIC ACID; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CASE REPORT; CHILD; DRUG COMBINATION; FATALITY; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CHILD; DEOXYCHOLIC ACID; DRUG COMBINATIONS; FATAL OUTCOME; HUMANS; IMMUNOCOMPROMISED HOST; MALE; PYRIMIDINES; TRIAZOLES;

EID: 33645823675     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Soubani A O, Chandrasekar P H. The clinical spectrum of pulmonary aspergillosis. Chest 2002; 121: 1988-99.
2. Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 1989; 114: 555-60.
3. Shetty D, Giri N, González C E, Pizzo P A, Walsh T J. Invasive aspergillosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1997; 16: 216-21.
4. Walmsley S, Devi S, King S, Schneider R, Richardson S, Ford-Jones L. Invasive Aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J 1993; 12: 673-82.
5. Denning D W. Invasive aspergillosis. Clin Infect Dis 1998, 26: 781-805.
6. Groll A H, Jaeger G, Allendorf A, Herrmann G, Schloesser R, Von Loewenich V. Invasive pulmonary aspergillosis in a critically ill neonate: case report and review of invasive aspergillosis during the first 3 months of life. Clin Infect Dis 1998; 27: 437-52.
7. Conesa D, Rello J, Valles J, Mariscal D, Ferreres J C. Invasive aspergillosis: a life-threatening complication of short-term steroid treatment. Ann Pharmacother 1995; 29: 1235-7.
8. Ko J P, Kim D H, Shepard J A. Pulmonary aspergillosis in an immunocompetent patient. J Thorac Imaging 2002; 17: 70-3.
9. McNeil M M, Nash S L, Hajjeh R A, Phelan M A, Conn L A, Plikaytis B D, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001; 33: 641-7.
10. Shaw F W, Warthen H J. Aspergillosis of bone. South Med J 1936; 29: 1070-1.
11. Bodey G. Fungal infection and fever of unknown origin in neutropenic patients. Am J Med 1986; 80: 112-9.
12. Allo M D, Miller J, Townsend T, Tan C. Primary cutaneous aspergillosis associated with Hickman intravenous catheters. N Engl J Med 1987; 317: 1105-8.
13. Steinbach W J. Pediatric aspergillosis. Disease and treatment differences in children. Pediatr Infect Dis J 2005; 24: 358-64.
14. Anderson L L, Giandoni M B, Keller R A, Grabski W J. Surgical wound healing complicated by Aspergillus infection in a non-immunocompromised host. Dermatol Surg 1995; 21: 799-801.
15. Gefter W B. The spectrum of pulmonary aspergillosis. J Thorac Imaging 1992; 7: 56-74.
16. Thomas K E, Owens C M, Veys P A, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol 2003; 33: 453-60.
17. Taccone A, Occhi M, Garaventa A, Manfredini L, Viscoli C. CT of invasive pulmonary aspergillosis in children with cancer. Pediatr Radiol 1993; 23: 177-80.
18. Caillot D, Casasnovas O, Bernard A, Couaillier J F, Durand C, Cuisenier B, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15: 139-47.
19. Ascioglu S, Rex J H, De Pauw B, Bennett J E, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplant: an international consensus. Clin Infect Dis 2002; 34: 7-14.
20. Fica A. Tratamiento de infecciones fúngicas sistémicas. III parte: Anfotericina B, aspectos farmacoeconómicos y decisiones terapéuticas. Rev Chil Infect 2004; 21: 317-26
21. Hartemink K J, Paul M A, Spijkstra J J, Girbes A R, Polderman KH. Immunoparalysis as a cause for invasive aspergillosis? Intensive Care Med 2003; 29: 2068-71.
22. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans W E, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170: 621-5.
23. Kwoun M O, Ling P R, Lydon E, Imrich A, Qu Z, Palombo J, et al. Immunologic effect of acute hyperglycemia in non diabetic rats. J Parenter Enteral Nutr 1997; 21: 91-5.
24. Pilleux L, Ponticas M, Carrasco C, León A, Salas P, Rodríguez C, et al. Hialohifomicosis invasiva hepatoesplénica. Comunicación de un caso. Rev Méd Chile 2000; 128: 641-6.
25. Hasejima N, Yamato K, Takezawa S, Kobayashi H, Kadoyama C. Invasive pulmonary aspergillosis associated with influenza B. Respirology 2005; 10: 116-9
26. Siddiqui A A, Shah A A, Bashir S H. Craniocerebral aspergillosis of sinonasal origin in immunocompetent patient: clinical spectrum and outcome in 25 cases. Neurosurgery 2004; 55: 602-11.
27. Karim M, Alam M, Shah A A, Ahmed R, Sheinkh H. Chronic invasive aspergillosis in apparently immunocompetent host. Clin Infect Dis 1997; 24: 723-33.
28. Pannuti C, Gingrich R, Pfaller M, Kao C, Wenzel R. Nosocomial pneumonia in patients having bone marrow transplant. Attributable mortality and risk factors. Cancer 1992; 69: 2653-62.
29. Saugier V, Devergie A, Sulahian A, Ribaud P, Traore F, Bourdeau E. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: Results of a 5 year retrospective study. Bone Marrow Transplant 1993; 12: 121-4.
30. Spreadbury C, Holden D, Aufauvre-Brown A, Bainbridge B, Cohen J. Detection of Aspergillus fumigatus by polymerase chain reaction. J Clin Microbiol 1993; 31: 615-21
31. Denning D W, Stevens D A. Antifungal and surgical treatment of invasive aspergillosis: Review of 2121 cases. Rev Infect Dis 1990; 12: 1147-201.
32. Ribrag V, Dreyfus F, Venot A, Leblong V, Lanore J J, Varet B. Prognostic factors of invasive pulmonary aspergillosis in leukemia patients. Leuk Lymphoma 1993; 10: 317-21.
33. Retamal C, Díaz C, Salamanca L, Ferrada L, Oro R. Aspergilosis pulmonar en Chile enfoque inmunológico. Bol Micol 1984; 2: 11-6.
34. Herbrecht R, Denning D W, Patterson T F, Bennett J E, Greene R E, Oestmann J W, et al. Invasive Fungal Infections Group of the European Organization for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-15.
35. Bidart T. Rol de voriconazol y caspofungina en terapia antifúngica. Rev Chil Infect 2004; 21 (Supl 1): S13-S19.
36. Maertens J, Raad I, Petrikkos G, Boogaerts M, Selleslag D, Petersen F, et al. for the Caspofungin Salvage Aspergillosis Study Group. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004; 39: 1563-71.
37. Walsh T J, Adamson P C, Seibel N L, Flynn P M, Neely M N, Schwartz C, et al. Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Antimicrob Agents Chemother 2005; 49: 4536-45.
38. Walsh T J, Karlsson M O, Driscoll T, Argüedas A, Adamson P, Saez-Llorens X, et al. Pharmacokinetics and safety of voriconazole in children after single or multiple-dose administration. Antimicrob Agents Chemother 2005; 48: 2166-72.